BDBM516556 US11053243, Example 100::benzyl (2S)-2-[5-(4-{5-[(1- {(2R)-2-[(tert-butoxycarbonyl) amino]-2-phenylacetyl}-L- prolyl)amino]-1H-indol-2- yl}phenyl)-1H-imidazol-2- yl]pyrrolidine-1-carboxylate

SMILES CC(C)(C)OC(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc2[nH]c(cc2c1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)OCc1ccccc1)c1ccccc1

InChI Key InChIKey=FJMYVIZJXDCLJX-ZEDFPVKGSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516556   

TargetGenome polyprotein(Hepatitis C Virus (Virus))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM516556(US11053243, Example 100 | benzyl (2S)-2-[5-(4-{5-[...)
Affinity DataEC50:  0.0310nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent